Cellular and molecular mechanisms of pulmonary vascular remodeling

Annual Review of Physiology

Volumn 59, Issue , 1997, Pages 89-144

  Stenmark, K R ^a   Mecham, R P ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endothelial cells; fibroblasts; lung development; pulmonary hypertension; smooth muscle cells; vascular development; vascular injury

Indexed keywords

CYTOKINE; GENE PRODUCT; SCLEROPROTEIN;

ANGIOGENESIS; BLOOD VESSEL INJURY; CELL SUBPOPULATION; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG FIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; ANIMALS, NEWBORN; BLOOD VESSELS; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; PULMONARY CIRCULATION;

EID: 0030934358     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.59.1.89     Document Type: Review

References (283)

1. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. 1991. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87:155-62
2. Allen KM, Haworth SG. 1989. Cytoskeletal features of immature pulmonary vascular smooth muscle cells: the influence of pulmonary hypertension on normal development. J. Pathol. 158:311-17
3. Arcot SS, Lipke DW, Gillespie MN, Olson JW. 1993. Alterations of growth-factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 46:1086-91
4. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, et al. 1994. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol. 267:H1777-84
5. Ashmore RC, Rodman DM, Sato K, Webb SA, O'Brien RF, et al. 1991. Paradoxical constriction of platelets by arteries from rats with pulmonary hypertension. Am. J. Physiol. 260:H1929-34
6. Assender JW, Southgate KM, Newby AC. 1992. Does nitric oxide inhibit smooth muscle proliferation? J. Cardiovasc. Pharmacol. 17(3):S104-7
7. Au YP, Kenagy RD, Clowes MM, Clowes AW. 1993. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23:177-82
8. Ausprunk DH. 1986. Distribution of hyaluronic acid and sulfated glycosaminoglycans during blood vessel development in the chick chorioallantoic membrane. Am. J. Anat. 177:313-31
9. Ausprunk DH, Dethlefsen SM, Higgins ER. 1991. Distribution of fibronectin, laminin and type IV collagen during development of blood vessels in the chick chorioallantoic membrane. In The Development of the Vascular System, ed. RN Feinberg, GK Sherer, R Auerbach, 14:93-108. Basel: Karger Issues Biomed. 192 pp.
10. Badesch DB, Orton EC, Zapp LM, Westcott JY, Hester J, et al. 1989. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 1:489-98
11. Bahadori L, Milder J, Gold LI, Botney MD. 1995. Active macrophage-associated TGF-β colocalizes with type I procollagen gene expression in atherosclerotic human hypertensive pulmonary arteries. Am. J. Pathol. 146:1140-49
12. Barer GR, Cai Y, Russell PC, Emery CJ. 1989. Reactivity and site of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes. Am. Rev. Respir. Dis. 140:1483-85
13. Barzu T, Herbert J-M, Desmouliere A, Carayon P, Pascal M. 1994. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment. J. Cell. Physiol. 160:239-48
14. Belknap JK, Orton EC, Ensley B, Tucker A, Stenmark KR. 1996. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am. J. Resp. Cell Mol. Biol. In press
15. Deleted in proof
16. Benitz WE, Bernfield M. 1990. Endothelial cell proteoglycans: possible mediators of vascular response to injury. Am. J. Respir. Cell Mol. Biol. 2:407-8
17. Benitz WE, Kelley RT, Anderson CM, Lorant DE, Bernfield M. 1990. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am. J. Respir. Cell. Mol. Biol. 2:13-24
18. Berk BC, Vekshtein V, Gordon HM, Tsuda T. 1989. Angiotensin-II-stimulated protein-synthesis in cultured vascular smooth-muscle cells. Hypertension 13:305-14
19. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3:211-20
20. Bhat GB, Block ER. 1992. Effect of hypoxia on phospholipid metabolism in porcine pulmonary artery endothelial cells. Am. J. Physiol. 262:L606-13
21. Bialecki RA, Kulik TJ, Colucci WS. 1992. Stretching increases calcium influx and efflux in cultured pulmonary arterial smooth muscle cells. Am. J. Physiol. 263:L602-6
22. Bishop JE, Reeves JT, Laurent GJ, eds. 1995. Pulmonary Vascular Remodeling. London: Portland. 278 pp.
23. Block ER, Patel JM, Edwards D. 1989. Mechanism of hypoxic injury to pulmonary artery endothelial cell plasma membranes. Am. J. Physiol. 257:C223-31
24. Bobik A, Grinpukel S, Little PJ, Grooms A, Jackson G. 1990. Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle. Biochem. Biophys. Res. Commun. 166:580-88
25. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. 1990. Growth-factor activity of endothelin on vascular smooth-muscle. Am. J. Physiol. 258:C408-15
26. Bonvallet ST, Zamora MR, Hasunuma K, Sato K, Hanasato N, et al. 1994. BQ 123 an ETA receptor antagonist attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol. 266:H1327-31
27. Botney MD, Bahadori L, Gold LI. 1994. Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-β. Am. J. Pathol. 144:286-95
28. Botney MD, Kaiser LR, Cooper JD, Mecham RP, Parghi D, et al. 1992. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am. J. Pathol. 140:357-64
29. Botney MD, Liptay MJ, Kaiser LR, Cooper JD, Parks WC, Mecham RP. 1993. Active collagen synthesis by pulmonary vascular cells in human primary pulmonary hypertension. Am. J. Pathol. 143:121-29
30. Botney MD, Parks WC, Crouch EC, Stenmark KR, Mecham RP. 1992. TGF-β-1 is decreased in remodeling hypertensive bovine pulmonary arteries. J. Clin. Invest. 89:1629-35
31. Brain SD, Crossman DC, Buckley TL, Williams TJ. 1989. Endothelin- demonstration of potent effects of the microcirculation of human and other species. J. Cardiovasc. Pharmacol. 13:S147-50
32. Carey DJ. 1991. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu. Rev. Physiol. 53:161-77
33. Castelott JJ, Addonzio ML, Rosenberg RD, Karnovsky MJ. 1981. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J. Cell. Biol. 90:372-79
34. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, et al. 1992. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327:70-75
35. Clemens DR. 1983. Age-dependent production of a competence factor by human fibroblasts. J. Cell. Physiol. 114:61-67
36. Clozel J-P, Saunier C, Hartemann D, Fischli W. 1991. Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia. J. Cardiovasc. Pharmacol. 17:36-40
37. Cook CL, Weiser MCM, Schwanz PE, Jones CL, Majack RA. 1993. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ. Res. 74:189-96
38. Cornfield DN, Stevens T, McMurtry IF, Abman SH, Rodman DM. 1993. Acute hypoxia increases cytosolic calcium in fetal pulmonary artery smooth muscle cells. Am. J. Physiol. 265:L53-56
39. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. 1982. Cell number and cell characteristics of the normal human lung. Am. Rev. Respir. Dis. 125:332
40. Crouch EC, Parks WC, Rosenbaum JL, Chang D, Whitehouse L, et al. 1989. Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension. Am. Rev. Respir. Dis. 140:1045-51
41. Das M, Stenmark KR, Dempsey EC. 1995. Enhanced growth of fetal and neonatal pulmonary artery adventitial fibroblasts is dependent on protein kinase C. Am. J. Physiol. 269:L660-67
42. Davidson JM, Hill KE, Mason ML, Giro MG. 1985. Longitudinal gradient of collagen and elastin gene expression in the porcine aorta. J. Biol. Chem. 260:1901-08
43. Delafontaine P, Lou H, Alexander RW. 1991. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 18:742-47
44. Dempsey EC. 1992. Hypoxia alone stimulates translocation of PKC and when combined with PMA can augment phorbol-ester-induced activation of the same pathway in bovine PA SMC. Am. Rev. Respir. Dis. 146:A568
45. Dempsey EC, Badesch DB, Dobyns E, Stenmark KR. 1994. Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: dependence on cell size, time of harvest, insulin-like growth factor-1, and auto-activation of protein kinase C. J. Cell Physiol. 160:469-81
46. Dempsey EC, Das M, Frid MG, Stenmark KR. 1996. Unique growth properties of neonatal pulmonary vascular cells: importance of time- and site-specific responses, cell-cell interaction, and synergy. J. Perinatol. 16:S2-11
47. Dempsey EC, McMurtry IF, O'Brien RF. 1991. Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am. J. Physiol. 260:L136-45
48. Dempsey EC, Stenmark KR, McMurtry IF, O'Brien RF, Voelkel NF, Badesch DB. 1990. Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J. Cell. Physiol. 144:159-65
49. Dempsey EC, Walchak SJ, Peach JL, Stenmark KR. 1992. Adult bovine PA adventitial fibroblasts, but not matched SMC, have a potential PKC-dependent autocrine growth loop. Am. Rev. Respir. Dis. 145:A481
50. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, et al. 1991. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324:1539-47
51. Durmowicz AG, Badesch DB, Stenmark KR. 1990. Elastin production under hypoxic conditions is influenced by vascular wall cell-cell interaction. Am. Rev. Respir. Dis. 141:A187
52. Durmowicz AG, Frid MG, Wohrley JD, Stenmark KR. 1996. Expression and localization of tropoelastin mRNA in the developing bovine pulmonary artery is dependent on vascular cell phenotype. Am. J. Respir. Cell Mol. Biol. 14:569-76
53. Durmowicz AG, Orton EC, Stenmark KR. 1993. Progressive loss of vasodilator responsive component of pulmonary hypertension in neonatal calves exposed to 4,570m. Am. J. Physiol. 265:H2175-83
54. Durmowicz AG, Parks WC, Hyde DM, Mecham RP, Stenmark KR. 1994. Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. Am. J. Pathol. 145:1411-20
55. Dzau VJ, Gibbons GH. 1993. Vascular remodeling: mechanisms and implications. J. Cardiovasc. Pharmacol. 21(1):S1-S5
56. Falanga V, Kirsner RS. 1993. Low oxygen stimulates proliferation of fibroblasts seeded as single cells. J. Cell. Physiol. 154:506-10
57. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, et al. 1993. Low oxygen tension increases mRNA levels of alpha-1 (I) procollagen in human dermal fibroblasts. J. Cell. Physiol. 157:408-12
58. Ferrara N, Houck K, Jakeman L, Leung DW. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev. 13:18-32
59. Flamme I, Breier G, Risau W. 1995. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol. 169:699-712
60. Form DM, Pratt BM, Madri JA. 1986. Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab. Invest. 55:521-30
61. Foster JA, Rich CB, Miller MF. 1990. Pulmonary fibroblasts, an in vitro model of emphysema. Regulation of elastin gene expression. J. Biol. Chem. 265:14444-49
62. Frid MG, Moiseeva EP, Stenmark KR. 1994. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ. Res. 75:669-81
63. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. 1992. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev. Biol. 153:185-93
64. Frid MG, Stenmark KR. 1994. An immature smooth muscle cell subpopulation exists in the normal adult bovine pulmonary arterial media. Am. J. Respir. Crit. Care Med. 149:A823
65. Frid MG, Stenmark KR. 1995. Distinct adult bovine arterial smooth muscle cell subpopulations exhibit unique growth characteristics in vitro. Am. J. Respir. Crit. Care Med. 151:A526
66. Fritze LM, Reilly CF, Rosenberg RD. 1985. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J. Cell. Biol. 100:1041-49
67. Fujita H, Shimokado K, Yutani C, Takaichi S, Masuda J, Ogata J. 1993. Human neonatal and adult vascular smooth muscle cells in culture. Exp. Mol. Pathol. 58:25-39
68. 2+ pump in cultured vascular smooth muscle cells. J. Biol. Chem. 264:4844-49
69. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. 1972. Granulation tissue as a contractile organ. A study of structure and function. J. Exp. Med. 135:719
70. Gay CG, Winkles JA. 1991. Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 88:296-300
71. Giaid A, Saleh D. 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333:214-21
72. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, et al. 1993. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328:1732-39
73. Gibbons GH, Pratt RE, Dzau VJ. 1992. Vascular smooth muscle cell hypertrophy versus hyperplasia. Autocrine transforming growth factor-β-1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:456-61
74. Gillespie MN, Rippetoe PE, Haven CA, Shiao R-T, Orlinska U, et al. 1989. Polyamines and epidermal growth-factor in monocrotaline-induced pulmonary-hypertension. Am. Rev. Respir. Dis. 140:1463-66
75. Glagov S, Ozoa AK. 1968. Significance of the relatively low incidence of atherosclerosis in the pulmonary, renal, and mesenteric arteries. Ann. NY Acad. Sci. 149:940-55
76. Glukhova MA, Frid MG, Koteliansky VE. 1990. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J. Biol. Chem. 265:13042-46
77. Glukhova MA, Frid MG, Shekhonin BV, Balabanov YV, Koteliansky VE. 1990. Expression of fibronectin variants in vascular and visceral smooth muscle cells in development. Dev. Biol. 141:1930-02
78. Glukhova MA, Kabakov AE, Belkin AM, Frid MG, Omatsky OI, et al. 1986. Metavinculin distribution in adult human tissues and cultured cells. FEBS Lett. 207:139-41
79. Glukhova MA, Kabakov AE, Frid MG, Ornatsky OL, Belkin AM, et al. 1988. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc. Natl. Acad. Sci. USA 85:9542-46
80. Gold ME, Wood KS, Byrns RE, Fukato J, Ignaro LJ. 1990. NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Proc. Natl. Acad. Sci. USA 87:4430-34
81. 2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA 86:6758-62
82. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. 1987. Structural characterization and biological functions of fibroblast growth factor. Endocrinol. Rev. 8:95-114
83. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. 1991. Expression of AT2 receptors in the developing rat fetus. J. Clin. Invest. 88:921-33
84. Hall SM, Haworth SG. 1986. Conducting pulmonary arteries: structural adaptation to extra-uterine life. Cardiovasc. Res. 21:208-16
85. Han RNN, Mawdsley C, Souza P, Tanswell AK, Post M. 1992. Platelet-derived growth factors and growth-related genes in rat lung. III. Immunolocalization during fetal development. Pediatr. Res. 31:323-29
86. Hasunuma K, Yamaguchi T, Rodman DM, O'Brien FR, McMurtry IF. 1991. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am. J. Physiol. 260(4):L97-104
87. Haven CA, Olson JW, Arcot SS, Gillespie MN. 1992. Polyamine transport and ornithine decarboxylase activity in hypoxic pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 7:286-92
88. Haworth SG. 1993. Pulmonary hypertension in childhood. Eur. Respir. J. 6:1037-43
89. Heath D, Wood E, Dushane J, Edwards J. 1959. The structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis. J. Pathol. Bacteriol. 77:443-50
90. Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. 1988. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J. Cell Biol. 107:307-19
91. Hedin U, Holm J, Hansson GK. 1991. Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am. J. Pathol. 139:649-56
92. Herbst TJ, McCarthy JB, Tsilibary EC, Furcht LT. 1988. Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J. Cell Biol. 106:1365-73
93. Hill DJ, Strain SF, Elstow SF, Swenne I, Milner RDG. 1986. Bifunctional action of transforming growth factor-β on DNA synthesis in early passage human fetal fibroblasts. J. Cell Physiol. 128:322-28
94. Hirata Y, Takagi Y, Fukunda Y, Marumo F. 1989. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225-28
95. 2+ influx. J. Biol. Chem. 263:9292-97
96. Hsieh H-J, Li N-Q, Frangos JA. 1991. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am. J. Physiol. 260:H642-46
97. Hung K-S, McKenzie JC, Mattioli L, Klein RM, Menon CD, Poulose AK. 1986. Scanning electron microscopy of pulmonary vascular endothelium in rats with hypoxia-induced hypertension. Acta Anat. 126:13-20
98. Hynes RO, Yamada KM. 1982. Fibronectins: multifunctional modular glycoproteins. J. Cell Biol. 95:369-77
99. Ido M, Sekiguchi K, Kikkawa U, Nishizuka Y. 1987. Phosphorylation of the EGF receptor from A431 epidermoid carcinoma cells by three distinct types of PKC. FEBS Lett. 219:215-18
100. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, et al. 1989. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Wature 338:557-62
101. Ishimitsu T, Uehara Y, Ishii M, Ikeda T, Matsuoka H, Sugimoto T. 1988. Thromboxane and vascular smooth-muscle cell-growth in genetically hypertensive rats. Hypertension 12:46-51
102. Jahn L, Kreuzer J, von Hodenberg E, Kubler W, Franke WW, et al. 1993. Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscler. Thromb. 13:1631-39
103. Jones KW, Shapero MH, Chevrettm M, Fournier REK. 1991. Subtractive hybridization cloning of tissue-specific extinguisher: TSE1 encodes a regulatory subunit of protein kinase A. Cell 66:861-72
104. 3H]-thymidine pulse-labeling of intimal, medial, and adventitial cells in microvessels and at the hilum. Am. Rev. Respir. Dis. 140:1471-77
105. Jones R, Reid L. 1995. Vascular remodeling in clinical and experimental pulmonary hypertensions. See Ref. 21a, 3:47-115
106. Jordana M, Schulman J, McSharky C, Irving LB, Newhouse MT, et al. 1988. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clinically derived fibroblasts from control and fibrotic tissue. Am. Rev. Respir. Dis. 137:579-84
107. Kanaleh MB. 1991. Endothelin, an endothelial dependent vasoconstrictor in scleroderma enhanced production and profibrotic action. Arthritis Rheum. 34:978-83
108. Kameji R, Otsuka H, Hayashi Y. 1980. Increase of collagen synthesis in pulmonary arteries of monocrotaline-treated rats. Experientia 36:441-42
109. Kapanci Y, Burgan S, Pietra GG, Conne B, Gabbiani G. 1990. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am. J. Pathol. 136:881-90
110. Katayose D, Ohe M, Yamauchi K, Ogata M, Shirato K, et al. 1993. Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am. J. Physiol. 264:L100-6
111. Kawahara Y, Sunako M, Tsuda T, Fukuzaki H, Fukumoto Y, Takai Y. 1988. Angiotensin-II induces expression of the c-fos gene through protein kinase-c activation and calcium mobilization in cultured vascular smooth-muscle cells. Biochem. Biophys. Res. Commun. 150:52-59
112. Kay JM, Keane PM, Suyama KL, Gauthier D. 1982. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension. Thorax 37:88-96
113. Keeley FW, Rabinovitch M. 1995. Vascular matrix metabolism in hypertension. See Ref. 21a, 5:149-69
114. Kim DK, Zhang L, Dzau VJ, Pratt RE. 1994. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J. Clin. Invest. 93:355-60
115. Kingsley DM. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-46
116. Kobayashi J, Wigle D, Childs T, Zhu L, Keeley FW, Rabinovitch M. 1994. Serum-induced vascular smooth muscle cell elastolytic activity through tyrosine kinase intracellular signalling. J. Cell. Physiol. 160:121-31
117. Kocher O, Gabbiani G. 1986. Expression of actin mRNA in rat aortic smooth muscle cells during development, experimental intimai thickening, and culture. Differentiation 32:245-51
118. Kocher O, Skalli O, Bloom WS, Gabbiani G. 1984. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimai thickening. Lab. Invest. 50:645-52
119. Kohno M, Chatani Y, Tanaka E, Hattori A, Nishizawa N. 1992. Mitogen-induced tyrosine phosphorylation of 41 kDa and 43 kDa proteins. Biochem. J. 287:917-24
120. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, et al. 1991. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat myocytes-possible role of protein kinase C activation. J. Biol. Chem. 266:1265-68
121. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. 1988. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth-muscle cells. FEBS Lett. 238:249-52
122. Kornblihtt AR, Umezawa K, Vige-Pedersen K, Baralle F. 1985. Primary structure of human fibronectin: Differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 4:1755-59
123. Kourembanas S, Hannan RL, Faller DV. 1990. Oxygen tension regulates the expression of the platelet-derived growth factor-β chain gene in human endothelial cells. J. Clin. Invest. 86:670-74
124. Kourembanas S, McQuillan LP, Leung GK, Faller DV. 1993. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:99-104
125. Kratochwil K, Dziadek M, Lohler J, Harbers K, Jaenisch R. 1986. Normal epithelial branching morphogenesis in the absence of collagen. Dev. Biol. 117:596-606
126. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. 1988. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells in capillary-like structures. J. Cell Biol. 107:1589-98
127. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, et al. 1995. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J. Clin. Invest. 96:293-300
128. Kuro-O M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, et al. 1989. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J. Biol. Chem. 264:18272-75
129. Langleben D, Serban L, Biais D, Mohamed F, Stewart DJ. 1991. Hypoxia stimulates endothelin-1 release from PA SMC in vitro. Circulation 84(II):A92
130. Lawson KA. 1983. Stage specificity in the mesenchyme requirement of rodent lung epithelium in vitro: a matter of growth control? J. Embryol. Exp. Morphol. 74:183-206
131. Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM. 1994. Characterization of cloned aortic smooth muscle cells from young rats. Am. J. Pathol. 144:1068-81
132. Lester DS, Collin C, Etcheberrigaray R, Alkon DL. 1991. Arachidonic acid and diacylglycerol act synergistically to activate protein kinase C in vitro and in vivo. Biochem. Biophys. Res. Commun. 179:1522-28
133. Leung DYM, Glagov S, Mathews MB. 1977. Elastin and collagen accumulation in rabbit ascending aorta and pulmonary trunk during postnatal growth. Circ. Res. 41:316-23
134. Levine AJ. 1993. The tumor suppressor genes. Annu. Rev. Biochem. 62:623-51
135. Li X, Tsai P, Wieder ED, Kribben A, Van Putten V, et al. 1994. Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J. Biol. Chem. 269:19653-58
136. Liptay MJ, Parks WC, Mecham RP, Roby J, Kaiser LR, et al. 1993. Neointimal macrophages co-localize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91:588-94
137. Lynch DC, Ansel PL, Levine RB. 1988. Effects of anoxia on gene expression in human endothelial cells. J. Cell Biol. 107(6):A581
138. MacCumber MW, Ross CA, Glaser BM, Snyder SH. 1989. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA 86:7285-89
139. Majack RA. 1995. Extinction of autonomous growth potential in embryonic:adult vascular smooth muscle cell heterokaryons. J. Clin. Invest. 95:464-68
140. Majack RA, Clowes AW. 1984. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 118:253-56
141. Majack RA, Majesky MW, Goodman LV. 1990. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J. Cell Biol. 111:139-47
142. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. 1992. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ. Res. 71:759-68
143. Maruyama K, Ye C, Woo M, Venkatacharya H, Lines LD, et al. 1991. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am. J. Physiol. 261:H1716-26
144. Masters JRW. 1976. Epithelial-mesenchymal interaction during lung development: the effect of mesenchymal mass. Dev. Biol. 51:98-108
145. Matsura H, Hakomori SI. 1985. The oncofetal domain of fibronectin defined by a monoclonal antibody FDC-6: it's presence in fetal and tumor tissues and its absence in those from normal tissue and plasma. Proc. Natl. Acad. Sci. USA 83:6517-21
146. Maxwell PH, Pugh CW, Ratcliffe PJ. 1993. Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc. Natl. Acad. Sci. USA 90:2423-27
147. McGowan SE. 1992. Extracellular matrix and the regulation of lung development and repair. FASEB J. 6:2895-904
148. Mecham RP, Stenmark KR, Parks WC. 1991. Connective tissue production by vascular smooth muscle in development and disease. Chest 99:43S-47S
149. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC, Griffin GL, et al. 1987. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 237:423-26
150. Meyrick B, Reid L. 1978. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab. Invest. 38:188-200
151. 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am. J. Pathol. 96:51-70
152. Meyrick B, Reid L. 1980. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. Lab. Invest. 42:603-15
153. Meyrick B, Reid L. 1980. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am. J. Pathol. 100:151-78
154. Meyrick BO, Perkett EA. 1989. The sequence of cellular and hemodynamic changes of chronic pulmonary hypertension induced by hypoxia and other stimuli. Am. Rev. Respir. Dis. 140:1486-89
155. Millauer B, Wizigmann-Voos S, Schnrch H, Martinez R, Moller NPH, et al. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-46
156. Mills AN, Haworth SG. 1987. Pattern of connective tissue development in swine pulmonary vasculature by immunolocalization. J. Pathol. 153:171-76
157. + exchange in vascular smooth muscle cells: role of protein kinase C. Am. J. Physiol. 260:C562-69
158. Monacci WT, Merrill MJ, Oldfield EH. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264:C995-1002
159. Morin FC, Stenmark KR. 1995. Persistent pulmonary hypertension of the newborn. State-of-the-Art. Am. J. Respir. Crit. Care Med. 151:2010-32
160. Morrell NW, Atochina EN, Morris KG, Danilov SM, Stenmark KR. 1995. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest. 96:1823-33
161. Morrell NW, Grieshaber SS, Danilov SM, Majack RA, Stenmark KR. 1996. Developmental regulation of angiotensin converting enzyme and angiotensin type I receptor in the rat pulmonary circulation. Am. J. Respir. Cell. Mol. Biol. 14:569-76
162. Murphy JD, Rabinovitch M, Goldstein JD, Reid LM. 1981. The structural basis of persistent pulmonary hypertension of the newborn infant. J. Pediatr. 98(6):962-67
163. Muthuchamy M, Pajak L, Howles P, Doetschman T, Wieczorek DF. 1993. Developmental analysis of trypomyosin gene expression in embryonic stern cells and mouse embryos. Mol. Cell. Biol. 13:3311-23
164. Myers B, Dubich M, Last JA, Ruche RB. 1983. Elastin synthesis during perinatal lung development in the rat. Biochem. Biophys. Acta 761:17-22
165. Nakaki T, Nakayama M, Kato R. 1990. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189:347-53
166. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. 1986. Stimulation of aortic smooth-muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA 83:674-78
167. Newby AC, Southgate KM, Assender JW. 1992. Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators. Herz 17(5):291-99
168. Neylon CB, Avdonin PV, Dilley RJ, Larsen MA, Tkachuk VA, Bobik A. 1994. Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types. Circ. Res. 75:733-41
169. Nilsson J, Von Euler AM, Dalsgaard CJ. 1985. Stimulation of connective-tissue cell-growth by substance-P and substance-K. Nature 315:61-63
170. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-14
171. O'Connor KJ, Knowles RG, Patel KD. 1991. Nitrovasodilators have proliferative as well as antiproliferative effects. J. Cardiovasc. Pharmacol. 17(3):S100-3
172. Ogawa S, Clauss M, Kuwabara K, Shreeniwas R, Butura C, et al. 1991. Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc. Natl. Acad. Sci. USA 88(21):9897-901
173. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. 1990. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J. Clin. Invest. 85(4):1090-98
174. Ogawa S, Koga S, Kuwabara K, Brett J, Morrow B, et al. 1992. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am. J. Physiol. 262:C546-54
175. Oho S, Rabinovitch M. 1994. Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am. J. Pathol. 145:202-10
176. Oka M, Hasunuma K, Webb SA, Stelzner TJ, Rodman DM, McMurtry IF. 1993. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am. J. Physiol. 264(8):L587-97
177. Oparil S, Narkates AJ, Jackson RM, Ann HS. 1988. Altered angiotensin converting enzyme in lung and extrapulmonary tissues of hypoxia adapted rats. J. Appl. Physiol. 65:218-27
178. Orton EC, LaRue SM, Ensley B, Stenmark KR. 1992. Bromodeoxyuridine labeling and DNA content of pulmonary arterial medial cells from hypoxia-exposed and non-exposed healthy calves. Am. J. Vet. Res. 53:1925-30
179. Orton EC, Raffestin B, McMurtry IF. 1990. Protein kinase C is a determinant of rat pulmonary vascular reactivity. Am. Rev. Respir. Dis. 141:654-58
180. Orton EC, Reeves JT, Stenmark KR. 1988. Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension. J. Appl. Physiol. 65:2459-67
181. Osborn M, Caselitz J, Weber K. 1981. Heterogeneity of intermediate filament expression in vascular smooth muscle: a gradient in desmin positive cells from the rat aortic arch to the level of the arteria iliaca communis. Differentiation 20:196-202
182. Owens GK. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-17
183. Owens GK. 1989. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am. J. Physiol. 257:H1755-65
184. Palmberg L, Claesson HE, Thyberg J. 1987. Leukotrienes stimulate initiation of DNA-synthesis in cultured arterial smooth-muscle cells. J. Cell Sci. 88:151-59
185. Pardanaud L, Yassine F, Dieterlen-Lievre F. 1989. Relationship between vasculo-genesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105:473-85
186. Parks WC, Mecham RP, Crouch EC, Orton EC, Stenmark KR. 1989. Response of lobar vessels to hypoxic pulmonary hypertension. Am. Rev. Respir. Dis. 140:1455-57
187. Patrignani P, Daffonchio L, Hernandez A, De Caterina R, Pelosi G, Patrono C. 1992. Release of contracting autocoids by aortae of normal and atherosclerotic rabbits. J. Cardiovasc. Pharmacol. 20(12):S208-10
188. Peacock AJ, Dawes KE, Shock A, Gray AJ, Reeves JT, Laurent GJ. 1992. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am. J. Respir. Cell Mol Biol. 7:492-99
189. Perkett EA, Badesch DB, Roessler MK, Stenmark KR, Meyrick B. 1992. Insulin-like growth factor-1 and pulmonary hypertension induced by continuous air embolization in sheep. Am. Rev. Respir. Cell Mol. Biol. 6:82-87
190. Perkett EA, Lyons RM, Moses HL, Brigham KL, Meyrick B. 1990. Transforming growth-factor-β activity in sheep lung lymph during the development of pulmonary-hypertension. J. Clin. Invest. 86:1459-64
191. Ploüet J, Schilling J, Gospodarowicz D. 1989. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 8:3801-6
192. Poiani GJ, Tozzi CA, Yohn SA, Pierce RA, Belsky SA, et al. 1990. Collagen and elastin metabolism in hypertensive pulmonary arteries of rats. Circ. Res. 66:968-78
193. Powel JT, Whitney PL. 1980. Postnatal development of rat lung. Biochem J. 188:1-8
194. Powell PP, Wang CC, Jones R. 1992. Differential regulation of the genes endoding platelet: derived growth-factor receptor and its ligand in rat lung during microvascular and alveolar wall remodeling in hyperoxia. Am. J. Respir. Cell. Mol. Biol. 7:278-85
195. Prosser IW, Stenmark KR, Suthar M, Mecham RP, Crouch EC, Parks WC. 1989. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am. J. Pathol. 135:1073-88
196. Pukac LA, Ottlinger ME, Kamovsky MJ. 1992. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267:3707-11
197. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90:7533-37
198. Rabinovitch M. 1987. Prostaglandins and structural changes in pulmonary arteries. Am. Rev. Respir. Dis. 136:777-79
199. Rabinovitch M, Bothwell T, Hayakawa B, Williams WG, Truster GA, et al. 1986. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. Lab. Invest. 55(6):632-53
200. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. 1981. Age and sex influence on pulmonary hypertension of chronic hypoxia and recovery. Am. J. Physiol. 240:H62-72
201. Rabinovitch M, Gamble W, Nada AS, Miettinen OS, Reid L. 1979. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236:H818-27
202. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. 1994. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J. Clin. Invest. 93:339-46
203. Rao GN, Berk BC. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:593-99
204. Rastinejad F, Blau HM. 1993. Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation. Cell 72:903-17
205. Reid LM, Davies P. 1989. Control of cell proliferation in pulmonary hypertension. In Lung Biology in Health and Disease, exec. ed. C Lenfant, Pulmonary Vascular Physiology and Pathophysiology, ed. EK Weir, JT Reeves, 38:541-611. New York: Dekker
206. Resink TJ, Hahn AWA, Scott-Burden T, Powell J, Weber E, Buhler FR. 1990. Inducible endothelin messenger-RNA expression and peptide secretion in cultured human vascular smooth-muscle cells. Biochem. Biophys. Res. Commun. 168:1303-10
207. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr. 1993. Platelet-derived growth factor β chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc. Natl. Acad. Sci. USA 90:4591-95
208. Riley DJ, Poiani GJ, Tozzi CA, Rosenbloom J, Pierce RA, Deak SB. 1986. Collagen and elastin gene expression in the hypertensive pulmonary artery of the rat. Trans. Assoc. Am. Phys. 99:180-88
209. + channel-mediated relaxation. Am. J. Physiol. 263:L88-94
210. Roman J, Little CW, McDonald JA. 1991. Potential role of RGD-binding integrins in mammalian lung branching morphogenesis. Development 112:551-58
211. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. 1993. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J. Pediatr. 123:109-14
212. Rothman A, Kulik TJ, Taubman MB, Berk BC, Smith CWJ, Nadal-Ginard B. 1992. Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation 86:1977-86
213. Rudnick D. 1933. Developmental capacities of the chick lung in chorioallantoic grafts. J. Exp. Zool. 66:125
214. Ruoslahti E, Engvall E, Hayman EG. 1981. Fibronectin: current concepts of its structure and function. Collagen Res. 1:95-128
215. Sadoshima J-I, Takahashi T, Jahn L, Izumo S. 1992. Roles of mechano-sensitive ion channels, cytoskeleton, and contractile activity in stretch-induced immediate-early gene expression and hypertrophy of cardiac myocytes. Proc. Natl. Acad. Sci. USA 89:9905-9
216. Salvaterra CG, Goldman WF. 1993. Acute hypoxia increases cytosolic calcium in cultured pulmonary arterial myocytes. Am. J. Physiol. 264:L323-28
217. Sannes PL, Burch KK, Khosla J. 1992. Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs. Am. J. Respir. Cell Mol. Biol. 7:230-37
218. Sappino AP, Schurch W, Gabbiani G. 1990. Biology of disease. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as markers of phenotypic modulation. Lab. Invest. 63:144-61
219. Sartore S, Scatena M, Chiavegato A, Faggin E, Giuriato L, Pauletto P. 1994. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J. Vasc. Res. 31:61-81
220. Schiffers PMH, Janssen GMJ, Fazzi GE, Struijker-Boudier HAJ, De Mey JGR. 1992. Endothelial modulation of DNA synthesis in isolated arteries of the rat. J. Cardiovasc. Pharmacol. 20(12):S124-27
221. Schor SL, Schor AM. 1987. Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. BioEssays 7:200-4
222. Schuster DP, Crouch EC, Parks WC, Johnson T, Botney MD. 1996. Angiotensin converting enzyme expression in primary pulmonary hypertension. Am. Rev. Respir. Crit. Care Med. In press
223. Schwartz SM. 1994. Biology of the neointima. Exp. Nephrol. 2:63-67
224. Schwartz SM, Foy L, Bowen-Pope DF, Ross R. 1990. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am. J. Pathol. 136:1417-28
225. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. 1988. Amiloride sensitive activation of S-6 kinase by angiotensin-II in cultured vascular smooth-muscle cells. Biochem. Biophys. Res. Commun. 151:583-89
226. Scott-Burden T, Resink TJ, Hahn AWA, Buhler FR. 1991. Angiotensin-induced growth related metabolism is activated in cultured smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Am. J. Hypertens. 4:183-88
227. Selmin O, Volpin D, Bressan GM. 1991. Changes of cellular expression of mRNA for tropoelastin in the intraembryonic arterial vessels of developing chick revealed by in situ hybridization. Matrix 11:347-58
228. Shanahan CM, Weissberg PL, Metcalfe JC. 1993. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 73:193-204
229. Shanmugan S, Corvol P, Gasc J-M. 1994. Ontogeny of the two angiotensin II type I receptor subtypes in rats. Am J. Physiol. 267:E828-36
230. Shapero MH, Langston AA, Fournier RE. 1994. Tissue-specific extinguisher loci in the human genome: a screening study based on random marking and transfer of human chromosomes. Somat. Cell Mol. Genet. 20:215-31
231. Shearman MS, Naor Z, Sekiguchi K, Kishimoto A, Nishizuka Y. 1989. Selective action of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett. 243:177-82
232. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, et al. 1990. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519-24
233. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB. 1994. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrinol. Metab. 79:316-22
234. 2+ pool content is linked to control of cell growth. Proc. Natl. Acad. Sci. USA 90:4986-90
235. Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, et al. 1992. Hypoxia-mediated induction of endothelial cell interleukin-1-α. J. Clin. Invest. 90:2333-39
236. Shubeita HE, Martinson EA, Vanbilsen M, Chien KR, Heller-Brown CJ. 1992. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. USA 89:1305-9
237. Shweiki D, Itin A, Soffer D, Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-48
238. Sibony M, Gasc J-M, Soubrier F, Alhenc-Galas F, Corvol P. 1993. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 21:827-35
239. Simonson MS, Wang Y, Jones JM, Dunn MJ. 1992. Protein kinase C regulates activation of mitogen-activated protein kinase and induction of proto-oncogene c-fos by endothelin-1. J. Cardiovasc. Pharmacol. 20:529-32
240. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. 1986. A monoclonal antibody against a-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell. Biol. 103:2787-96
241. Smith LE, Durmowicz AG, Stenmark KR. 1995. Target cell related differences in the anti-proliferative effects of nitric oxide (NO) on cultured vascular smooth muscle cells (VSMC). Am. J. Respir. Crit. Care Med. 151:A517
242. Starksen NF, Simpson PC, Bishopric N, Coughlin SR, Lee WMF, et al. 1986. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc. Natl. Acad. Sci. USA 83:8348-50
243. Stelzner TF, O'Brien RF, Sato K, Weil JV. 1988. Hypoxia-induced increases in pulmonary transvascular protein escape in rats. J. Clin. Invest. 82:1840-47
244. Stelzner TJ, O'Brien RF, Yanagisawa M, Sakurai T, Sato K, et al. 1992. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am. J. Physiol. 262:L614-20
245. Stenmark KR, Aldashev A, Orton EC, Durmowicz AG, Badesch DB, et al. 1991. Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension. Am. J. Physiol. Suppl. 261:97-104
246. Stenmark KR, Badesch DB, Dempsey EC, Frid M, Mecham RP, Parks WC. 1993. Regulation of pulmonary vascular wall cell growth: developmental and site-specific heterogeneity. Eur. Respir. Rev. 3:629-37
247. Stenmark KR, Badesch DB, Durmowicz AG, Voelkel NF. 1991. Control of vascular tone and cell proliferation in the pulmonary circulation. In Basic Mechanisms of Pediatric Respiratory Disease Cellular and Integrative, ed. V Chernick, RB Mellins, pp. 169-87. Philadelphia: Decker
248. Deleted in proof
249. Stenmark KR, Durmowicz AG, Dempsey EC. 1995. Modulation of vascular wall cell phenotype in pulmonary hypertension. See Ref. 21a, 6:171-212
250. Deleted in proof
251. Stenmark KR, Fasules J, Hyde DM, Voelkel NF, Henson J, et al. 1987. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300m. J. Appl. Physiol. 62:821-30
252. Stenmark KR, Majack RA. 1991. Response of the developing pulmonary circulation to injury. In Developmental Mechanisms of Disease in the Newborn. Rep. 101st Ross Conf. Pediatric Res., pp. 102-10
253. Stenmark KR, Mecham RP, Durmowicz AG, Roby JB, Parks WC. 1994. Persistence of (he fetal pattern of tropoelastin gene expression in severe neonatal pulmonary hypertension. J. Clin. Invest. 93:1234-42
254. Stenmark KR, Orton EC, Crouch EC, Parks WC, Voelkel NF, et al. 1988. Vascular remodeling in neonatal pulmonary hypertension: role of the smooth muscle cell. Chest 92:S127-32
255. Stewart DJ, Levy RP, Cernacek P, Langleben D. 1991. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann. Intern. Med. 114:464-69
256. Storch TG, Talle GD. 1988. Oxygen concentration regulates the proliferative response of human fibroblasts to serum and growth factors. Exp. Cell Res. 175:317-25
257. Stubbs CD. 1983. Membrane fluidity: structure and dynamics of membrane lipids. Essays Biochem. 19:1-39
258. Stubbs CD, Smith AD. 1984. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim. Biophys. Acta 779:89-137
259. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T. 1989. A novel vasoactive peptide endothelin stimulates mitogenesis through insitol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264:7856-61
260. Tanaka Y, Bernstein ML, Mecham RP, Patterson GA, Cooper JD, Botney MD. 1996. Site-specific responses to monocrotaline-induced vascular injury: evidence for two distinct mechanisms of remodeling. Am. J. Res. Cell Mol. Biol. In press
261. Tanaka Y, Schuster DP, Davis EC, Patterson GA, Botney MD. 1996. The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. J. Clin. Invest. 98:434-42
262. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, et al. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1579-86
263. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. 1990. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Atherosclerosis 10:966-90
264. Thyberg J, Hultgardh-Nilsson A. 1994. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276:263-71
265. Todorovich-Hunter L, Dodo H, Ye C, McCready L, Keeley FW, Rabinovitch M. 1992. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am. Rev. Respir. Dis. 146:213-23
266. Townsend SF, Han VKM, Stenmark KR. 1994. Persistence of the fetal pattern of IGF-II expression in the adventitia of small pulmonary arteries in neonatal hypoxic pulmonary hypertension. Growth Regul. 4(1):S12
267. Tozzi CA, Poiani GJ, Harangozo AM, Boyd CD, Riley DJ. 1989. Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J. Clin. Invest. 84:1005-12
268. Tuder RM, Flook BE, Voelkel NF. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798-807
269. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA. 1993. Ontogeny of type I angiotensin II receptor gene expression in the rat. J. Clin. Invest. 91:530-37
270. Turla MB, Thompson MM, Corjay MH, Owens GK. 1991. Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Circ. Res. 68:288-99
271. Ungari S, Katari RS, Alessandri G, Gullino PM. 1985. Cooperation between fibronectin and heparin in the mobilization of capillary endothelium. Invasion Metastasis 5:193-205
272. Voelkel NF, Badesch DB, Zapp LM, Stenmark KR. 1990. Impaired prostacyclin synthesis of endothelial cells derived from hypertensive calf pulmonary arteries. Prog. Respir. Res. 26:63-69
273. Voelkel NF, Tuder RM, Bridges J, Arend WP. 1994. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am. J. Respir. Cell Mol. Biol. 11:664-75
274. Wagenvoort CA, Wagenvoort N. 1977. Pathology of Pulmonary Hypertension. New York: Wiley & Sons
275. Weiser MCM, Grieshaber NA, Schwartz PE, Majack RA. 1996. Perlecan heparan sulfates regulate Oct-1 gene expression in vascular smooth muscle cells. Mol. Biol. Cell. In press
276. Weiser MCM, Grieshaber SS, Belknap JK, Kinsella MG, Majack RA. 1996. Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol. In press
277. Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. 1993. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J. Cell Biol. 123:741-47
278. Winlove CP, Bishop JE, Chambers RC, Laurent GJ. 1995. The structure and function of extracellular matrix in the pulmonary vasculature. See Ref. 21a, 2:21-46
279. Wohrley JD, Frid MG, Orton EC, Belknap JK, Stenmark KR. 1995. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J. Clin. Invest. 96:273-81
280. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. 1993. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-98
281. Ye C, Rabinovitch M. 1991. Inhibition of elastolysis by SC37698 (Searle) reduces development and progression of monocrotaline pulmonary hypertension. Am. J. Physiol. 261:H1255-67
282. Zanellato AM, Borrione AC, Giuriato L, Tonello M, Scannapieco G, et al. 1990. Myosin isoforms and cell heterogeneity in vascular smooth muscle. I. Developing and adult bovine aorta. Dev. Biol. 141:431-46
283. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, et al. 1993. Deletion of the paired alpha-5(IV) and alpha-6(IV) collagen genes in inherited smooth muscle tumors. Science 261:1167-69